open access
Coronary microvascular dysfunction in the context of long COVID-19: What is the effect of anti-inflammatory treatment? Author’s reply
Affiliations- Clinical Department of Internal Medicine and Occupational Diseases, Hypertension and Clinical Oncology, Faculty of Medicine, Wroclaw Medical University, Wrocław, Poland
- Witelon Collegium State University, Legnica, Poland
- Department of Cardiology, Provincial Specialized Hospital in Legnica, Legnica, Poland
- Department of Cardiology, The Copper Health Center (MCZ), Lubin, Poland
- 1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland
open access
Abstract
Abstract
About this articleTitle
Coronary microvascular dysfunction in the context of long COVID-19: What is the effect of anti-inflammatory treatment? Author’s reply
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Letter to the Editor
Published online
2023-02-06
Page views
38
Article views/downloads
76
DOI
10.33963/KP.a2023.0040
Pubmed
Authors
Adrian Doroszko
Piotr Rola
Szymon Włodarczak
Maciej Lesiak
Adrian Włodarczak
References (7)- Dimitrios P, Dimosiari A, Michailidis T. Coronary microvascular dysfunction in the context of long COVID-19: What is the effect of anti-inflammatory treatment? Kardiol Pol. 2022 [Epub ahead of print].
- Rola P, Włodarczak A, Włodarczak S, et al. Invasive assessment of coronary microvascular dysfunction in patients with long COVID: Outcomes of a pilot study. Kardiol Pol. 2022; 80(12): 1252–1255.
- Carnevale D, Wenzel P. Mechanical stretch on endothelial cells interconnects innate and adaptive immune response in hypertension. Cardiovasc Res. 2018; 114(11): 1432–1434.
- Zheng YY, Ma YT, Zhang JY, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020; 17(5): 259–260.
- Yilmaz O, Afsar B, Ortiz A, et al. The role of endothelial glycocalyx in health and disease. Clin Kidney J. 2019; 12(5): 611–619.
- Chelazzi C, Villa G, Mancinelli P, et al. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care. 2015; 19(1): 26.
- Bacchiega BC, Bacchiega AB, Usnayo MJ, et al. Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study. J Am Heart Assoc. 2017; 6(3).
